Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2026-01-02 @ 8:05 AM
Study NCT ID:
NCT01366092
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-11
First Post:
2011-06-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-07
Start Date Type:
None
Primary Completion Date:
2014-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2011-06-02
First Submit QC Date:
None
Study First Post Date:
2011-06-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-12-18
Results First Submit QC Date:
None
Results First Post Date:
2015-01-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-10
Last Update Post Date:
2025-09-11
Last Update Post Date Type:
ESTIMATED